165 related articles for article (PubMed ID: 2560341)
1. Increased purine nucleotide degradation in the central nervous system (CNS) in PRPP synthetase superactivity.
Jiménez ML; Puig JG; Mateos FA; Ramos TH; Melián JS; Nieto VG; Becker MA
Adv Exp Med Biol; 1989; 253A():9-13. PubMed ID: 2560341
[No Abstract] [Full Text] [Related]
2. Neurodevelopmental impairment and deranged PRPP and purine nucleotide synthesis in inherited superactivity of PRPP synthetase.
Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
Adv Exp Med Biol; 1989; 253A():15-22. PubMed ID: 2483028
[No Abstract] [Full Text] [Related]
3. Abnormal purine and pyrimidine metabolism in inherited superactivity of PRPP synthetase.
Bory C; Chantin C; Boulieu R
Adv Exp Med Biol; 1994; 370():15-8. PubMed ID: 7660879
[No Abstract] [Full Text] [Related]
4. [Metabolism of purine nucleotides in the central nervous system in patients with phosphoribosylpyrophosphate synthetase hyperactivity and neurosensory deafness].
López Jiménez M; García Puig J; Mateos Antón F; Ramos Hernández T; Sebastián Melián J; García Neito V
Neurologia; 1990 Jan; 5(1):14-7. PubMed ID: 2163266
[TBL] [Abstract][Full Text] [Related]
5. Inherited superactivity of phosphoribosylpyrophosphate synthetase: association of uric acid overproduction and sensorineural deafness.
Becker MA; Puig JG; Mateos FA; Jimenez ML; Kim M; Simmonds HA
Am J Med; 1988 Sep; 85(3):383-90. PubMed ID: 2843048
[TBL] [Abstract][Full Text] [Related]
6. [PRPP synthetase superactivity].
Fujimori S
Nihon Rinsho; 1996 Dec; 54(12):3309-14. PubMed ID: 8976111
[TBL] [Abstract][Full Text] [Related]
7. Superactive phosphoribosylpyrophosphate synthetase with altered regulatory and catalytic properties.
Becker MA; Raivio KO; Bakay B; Adams WB; Nyhan WL
Adv Exp Med Biol; 1980; 122A():387-92. PubMed ID: 6158850
[No Abstract] [Full Text] [Related]
8. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
Zoref E; De Vries A; Sperling O
J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
[TBL] [Abstract][Full Text] [Related]
9. PRPP and purine nucleotide metabolism in human lymphoblasts with both PRPP synthetase superactivity and HGPRT deficiency.
Becker MA; Kim M; Husain K
Adv Exp Med Biol; 1989; 253B():13-20. PubMed ID: 2481968
[No Abstract] [Full Text] [Related]
10. NAD synthesis by erythrocytes in phosphoribosylpyrophosphate synthetase (PRPPs) superactivity.
Micheli V; Simmonds HA
Adv Exp Med Biol; 1989; 253A():1-7. PubMed ID: 2560329
[No Abstract] [Full Text] [Related]
11. Synthesis and metabolic fate of purine nucleotides in cultured fibroblasts from normal subjects and from purine overproducing mutants.
Zoref E; Sivan O; Sperling O
Biochim Biophys Acta; 1978 Dec; 521(2):452-8. PubMed ID: 216390
[No Abstract] [Full Text] [Related]
12. Superactivity of human phosphoribosyl pyrophosphate synthetase due to altered regulation by nucleotide inhibitors and inorganic phosphate.
Becker MA; Losman MJ; Wilson J; Simmonds HA
Biochim Biophys Acta; 1986 Jun; 882(2):168-76. PubMed ID: 2423135
[TBL] [Abstract][Full Text] [Related]
13. PRPP synthetase superactivity in lymphoblast lines.
Becker MA; Losman MJ; Rimon D; Kim M
Adv Exp Med Biol; 1986; 195 Pt A():51-8. PubMed ID: 3014839
[No Abstract] [Full Text] [Related]
14. Gout with superactive phosphoribosylpyrophosphate synthetase due to increased enzyme catalytic rate.
Becker MA; Losman MJ; Itkin P; Simkin PA
J Lab Clin Med; 1982 Apr; 99(4):495-511. PubMed ID: 6174658
[TBL] [Abstract][Full Text] [Related]
15. Inherited phosphoribosylpyrophosphate synthetase superactivity due to aberrant inhibitor and activator responsiveness.
Becker MA; Losman MJ; Simmonds HA
Adv Exp Med Biol; 1986; 195 Pt A():59-66. PubMed ID: 3014841
[No Abstract] [Full Text] [Related]
16. Phosphoribosylpyrophosphate synthetase superactivity. A study of five patients with catalytic defects in the enzyme.
Becker MA; Losman MJ; Rosenberg AL; Mehlman I; Levinson DJ; Holmes EW
Arthritis Rheum; 1986 Jul; 29(7):880-8. PubMed ID: 3017368
[TBL] [Abstract][Full Text] [Related]
17. Possible metabolic basis for GTP depletion in red cells of patients with PRPP synthetase superactivity.
Giacomello A; Salerno C
Adv Exp Med Biol; 1991; 309B():253-6. PubMed ID: 1664182
[No Abstract] [Full Text] [Related]
18. Urinary and cerebrospinal fluid oxypurine levels and allopurinol metabolism in the Lesch-Nyhan syndrome.
Sweetman L
Fed Proc; 1968; 27(4):1055-9. PubMed ID: 5658472
[No Abstract] [Full Text] [Related]
19. Phosphoribosylpyrophosphate synthetase superactivity: detection, characterization of underlying defects, and treatment.
Becker MA
Adv Exp Med Biol; 1984; 165 Pt A():91-96. PubMed ID: 6326492
[No Abstract] [Full Text] [Related]
20. Superactivity of phosphoribosylpyrophosphate synthetase, due to feedback resistance, causing purine overproduction and gout.
Sperling O; Boer P; Brosh S; Zoref E; de Vries A
Ciba Found Symp; 1977; (48):143-64. PubMed ID: 204460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
